DocGo Inc.

NASDAQ:DCGO

Medical - Care Facilities

Healthcare
$0.71 -4.29%

-$0.02 today

Market cap
$70.14M
Beta
1.00
P/E (TTM)
-0.3
EPS (TTM)
-$1.90
52W Low $0.49High $1.78

Volume 1.64M

Average 0.87M

DCGO Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

DocGo Inc.NASDAQ: DCGO

Total Assets · Q1 FY2026 · quarter ended Mar 2026

Total assets falls 51.4% from a year ago

Total assets stood at $209.23M at the end of Q1 FY2026, down 51.4% from a year earlier and down 3.6% from the prior quarter. Over 3 fiscal years it compounded at -18.0% a year.

Context

  • Total assets increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total assets keeps falling in the next quarterly balance sheet after a -51.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$209.23M-3.6% QoQ
Last fiscal yearDec 2025
$217.1M-52.4% YoY
Year agoMar 2025
$430.79M-51.4% since
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-51.4%——
1 year-52.4%——
3-year CAGR-18.0%——
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
217.1M USD
Year-over-year change
-52.4%
4-year CAGR
-8.5%

Total Assets vs competitors

How DCGO compares with its peers on the latest reported figures

  • DCGO's Mar 2026 total assets of $209.23M is the 3rd highest of the 9 companies compared; the peer median is $86.94M.
  • Its year-over-year change of -51.4% is the lowest of 9, against a peer median of +29.1%.
  • Over three fiscal years its annual growth of -18.0% compares with a peer median of -2.4%.
DCGO Competitors Peer median
Total Assets for DCGO and competitors
Company Period Latest balance YoY 3-year CAGR
OVIDOvid Therapeutics Inc.Mar 2026$225.63M +176.3%-0.9%
MGNXMacroGenics, Inc.Mar 2026$217.87M -3.0%-3.9%
DCGODocGo Inc.Mar 2026$209.23M -51.4%-18.0%
PRLDPrelude Therapeutics IncorporatedMar 2026$119.64M -15.3%-13.8%
IMMXImmix Biopharma, Inc.Mar 2026$95.82M +381.7%+91.6%
MBOTMicrobot Medical Inc.Mar 2026$78.07M +152.7%+104.5%
COYACoya Therapeutics, Inc.Mar 2026$53.27M +38.7%+81.2%
RCELAVITA Medical, Inc.Mar 2026$51.54M -25.9%-16.9%
VANIVivani Medical, Inc.Mar 2026$42.35M +19.5%-8.3%
Peer median (excluding DCGO) $86.94M+29.1%-2.4%

Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents175.54M157.34M59.29M89.24M51.02M
Short-term Investments00000
Net Receivables78.38M103M262.08M210.9M92.89M
Inventory04.48M000
Other Current Assets06.27M17.5M4.34M3.7M
Total Current Assets256.03M271.08M338.87M304.49M152.4M
Property, Plant & Equipment (Net)26.24M39.37M38.42M42.18M43.5M
Goodwill8.69M38.9M47.54M47.43M0
Intangible Assets10.68M22.97M37.68M25.73M0
Long-term Investments4.16M597.98K553.57K5.55M0
Tax Assets09.96M11.89M8.42M538.86K
Other Non-current Assets3.81M10.4M15.5M21.83M20.67M
Total Non-current Assets53.57M122.2M151.58M151.13M64.7M
Total Assets309.6M393.28M490.45M455.62M217.1M
Account Payables15.83M21.58M19.83M28.36M11.11M
Short-term Debt626.33K664.91K25.03M30.01M51.74K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities11.89M49.38M39.81M27.4M23.91M
Total Current Liabilities57.88M100.16M170.12M121.81M67.49M
Long-term Debt1.3M1.24M41.59K5.22K183.84K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13.52M0004.78M
Total Non-current Liabilities24.67M14.19M15.16M18.64M23.74M
Total Liabilities82.55M114.35M185.28M140.44M91.23M
Common Stock10.01K10.24K10.41K10.19K9.86K
Retained Earnings(63.56M)(28.97M)(21.39M)(1.4M)(183.8M)
Accumulated OCI(32.5K)741.21K1.48M1.22M2.39M
Other Stockholders Equity00000
Minority Interest7.48M5.7M4.38M(5.74M)(18.14M)
Total Equity227.06M278.93M305.17M315.18M125.87M
Total Debt16.51M19.91M46.5M57.19M29.18M
Net Debt(159.03M)(137.42M)(12.79M)(32.05M)(21.84M)

DocGo Inc.

NASDAQ:DCGO

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.